DBD vs PAR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 10, 2026

DBD

45.3
AI Score
VS
DBD Wins

PAR

40.0
AI Score

Investment Advisor Scores

DBD

45score
Recommendation
HOLD

PAR

40score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric DBD PAR Winner
Forward P/E 12.6422 9.2678 PAR
PEG Ratio 0 0.7726 Tie
Revenue Growth 5.2% 15.0% PAR
Earnings Growth -82.9% 0.0% PAR
Tradestie Score 45.3/100 40.0/100 DBD
Profit Margin 2.0% -12.2% DBD
Beta 1.00 1.00 Tie
AI Recommendation HOLD EXTENDED Tie

Relative Price Performance (Last 90 Days)

DBD 1M: -12.5% · 3M: -21.0% PAR 1M: +38.4% · 3M: +19.6%

Current Technical Phase

DBD

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.8%), weak momentum, RSI 38

RSI (14): 37.7 · Price: $57.04

PAR

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 81

RSI (14): 81.0 · Price: $22.26

Fundamentals Snapshot

Metric DBD PAR
Market Cap — —
Forward P/E 9.3 17.1
Trailing P/E 28.5 —
Revenue (TTM) — —
Revenue Growth 0.1% 0.2%
Gross Margin 0.3% 0.4%
Operating Margin 0.1% 0.0%
EPS 2.01 -1.53
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, DBD is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.